Oncolytic Virotherapy to Enhance PReoperative IMmunotherapy Efficacy in Patients With Proficient Mismatch Repair (pMMR) Rectal Cancer

​ Conditions: Rectal Cancer Patients

Interventions: Drug: BT-001 followed by Pembrolizumab (PD-1 Blocking Antibody)

Sponsors: Henry Smith; Transgene; Rigshospitalet, Denmark

Recruiting Conditions: Rectal Cancer Patients
Interventions: Drug: BT-001 followed by Pembrolizumab (PD-1 Blocking Antibody)
Sponsors: Henry Smith; Transgene; Rigshospitalet, Denmark
Recruiting